A new sector may soon replace energy at the top of the heap.

2 Best Biotech Stocks to Buy Right Now

10:53am, Saturday, 11'th Jun 2022
These two pharma stocks boast 3%-plus dividend yields, double the S&P 500 index's 1.5% dividend yield.
Finding stocks that combine quality, growth and value into one package is challenging, but orthodontic device stock ALGN fits the bill. The post One High-Quality Stock You Need to Buy Right Now appear
Gina Sanchez, Lido Advisors chief market strategist, joins ‘The Exchange' to discuss her investment picks including Berkshire Hathaway, Mr. Cooper Group and Merck and her bail on AT&T.

Merck (MRK) Stock Moves -1.65%: What You Should Know

09:45pm, Thursday, 09'th Jun 2022 Zacks Investment Research
Merck (MRK) closed the most recent trading day at $88, moving -1.65% from the previous trading session.

Roche (RHHBY) Gets EU Nod for Lunsumio, Tecentriq Label Expansion

03:35pm, Thursday, 09'th Jun 2022 Zacks Investment Research
Roche (RHHBY) obtains EU approval for Lunsumio for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma (FL) and label expansion of Tecentriq.
If any investor has stood the test of time, it is Warren Buffett. For years, the “Oracle of Omaha” has had a rock-star-like presence in the investing world.
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Robert M. Davis, chief executive officer and president, and Dean
Merck & Co., Inc. (NYSE:MRK ) ASCO 2022 Oncology Event Conference Call June 7, 2022 8:00 AM ET Company Participants Dean Li - Executive Vice President & President of Merck Research Laboratories Eliav
Merck & Co., Inc. (NYSE:MRK) has just pulled back to the $90 level after its recent all-time high, a level that served as prior resistance.

Bristol Myers (BMY) to Acquire Turning Point, Withdraws sBLA

05:24pm, Monday, 06'th Jun 2022 Zacks Investment Research
Bristol Myers (BMY) is set to acquire Turning Point to bolster its oncology portfolio. The company also withdraws its sbLA for Reblozyl.

Big call buying in this mega cap pharma stock

02:28pm, Monday, 06'th Jun 2022
(OPTIMIZED VIDEO SPECIFIC DESCRIPTION) » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC Turn to CNBC TV for the latest stock market ne
Dr. Scott Gottlieb, former FDA commissioner and CNBC contributor, joins CNBC's 'Squawk Box' to discuss the top drug trial data coming out of the American Society of Clinical Oncology conference in Ch

Can the Best-Selling Drugs of 2021 Repeat Their Performance?

09:43am, Sunday, 05'th Jun 2022 The Motley Fool
These were the industry's bestsellers last year, but how long can they stay on top?
These blue-chip stocks with dividends offer a healthy income stream and potentially strong gains through capital appreciation. The post 7 Blue-Chip Stocks With Dividends to Add to Your Q2 Buy List app
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE